Skip to main content

Loteprednol Etabonate

NDC 85766-193 · Sportpharm LLC

Generic nameLoteprednol Etabonate
Dosage formSUSPENSION/ DROPS
RouteOPHTHALMIC
Active ingredient(s)LOTEPREDNOL ETABONATE
Strength2 mg/mL
Pharmacologic classCorticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
Marketing categoryANDA

Packages

85766-193-05 — 1 BOTTLE, DROPPER in 1 CARTON (85766-193-05) / 5 mL in 1 BOTTLE, DROPPER

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

46708-801 — Loteprednol etabonate and Tobramycin, 60219-1362 — loteprednol etabonate, 60219-1366 — loteprednol etabonate, 60219-1367 — loteprednol etabonate, 62332-801 — Loteprednol etabonate and Tobramycin, 62756-232 — Loteprednol Etabonate, 70244-034 — Loteprednol Etabonate, 70244-035 — Loteprednol Etabonate, 70244-036 — Loteprednol Etabonate, 70748-300 — loteprednol etabonate, 71571-121 — loteprednol etabonate, 71571-333 — loteprednol etabonate, 72485-630 — Loteprednol Etabonate, 72485-653 — Loteprednol Etabonate, 72485-665 — Loteprednol Etabonate, 72603-324 — LOTEPREDNOL ETABONATE, 82260-299 — loteprednol etabonate, 82260-358 — loteprednol etabonate and tobramycin, 82260-361 — loteprednol etabonate, 82260-508 — loteprednol etabonate, +10 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels